{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T18:33:30Z","timestamp":1789065210249,"version":"build-2803163510"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T00:00:00Z","timestamp":1604016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T00:00:00Z","timestamp":1604016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100012155","name":"National Institute for Medical Research Development","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012155","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s00228-020-03031-7","type":"journal-article","created":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T15:02:41Z","timestamp":1604070161000},"page":"547-554","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Protective effect of flumazenil infusion in severe acute benzodiazepine toxicity: a pilot randomized trial"],"prefix":"10.1007","volume":"77","author":[{"given":"Akram Sadat","family":"Razavizadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasim","family":"Zamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pardis","family":"Ziaeefar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Ebrahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4370-0544","authenticated-orcid":false,"given":"Hossein","family":"Hassanian-Moghaddam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,30]]},"reference":[{"issue":"3","key":"3031_CR1","first-page":"247","volume":"88","author":"MF Weaver","year":"2015","unstructured":"Weaver MF (2015) Prescription Sedative Misuse and Abuse. Yale J Biol Med 88(3):247\u2013256 eCollection 2015 Sep. Review","journal-title":"Yale J Biol Med"},{"issue":"10","key":"3031_CR2","doi-asserted-by":"publisher","first-page":"962","DOI":"10.3109\/15563650.2015.1102927","volume":"53","author":"JB Mowry","year":"2015","unstructured":"Mowry JB, Spyker DA, Brooks DE, McMillan N, Schauben JL (2015) 2014 Annual Report of the American Association of Poison Control Centers\u2019 National Poison Data System (NPDS): 32nd Annual Report. Clin Toxicol (Phila) 53(10):962\u20131147","journal-title":"Clin Toxicol (Phila)"},{"issue":"12","key":"3031_CR3","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1080\/15563650.2018.1533727","volume":"56","author":"DD Gummin","year":"2017","unstructured":"Gummin DD, Mowry JB, Spyker DA, Brooks DE, Osterthaler KM, Banner W (2017) Annual Report of the American Association of Poison Control Centers\u2019 National Poison Data System (NPDS): 35TH Annual Report. Clin Toxicol (Phila). 2018 Dec 56(12):1213\u20131415","journal-title":"Clin Toxicol (Phila)"},{"issue":"2","key":"3031_CR4","doi-asserted-by":"publisher","first-page":"135","DOI":"10.2165\/00002018-200427020-00004","volume":"27","author":"NA Buckley","year":"2004","unstructured":"Buckley NA, McManus PR (2004) Changes in fatalities due to overdose of anxiolytic and sedative drugs in the UK (1983-1999). Drug Saf 27(2):135\u2013141","journal-title":"Drug Saf"},{"issue":"3","key":"3031_CR5","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2165\/00002018-199717030-00004","volume":"17","author":"AA Weinbroum","year":"1997","unstructured":"Weinbroum AA, Flaishon R, Sorkine P, Szold O, Rudick V (1997) A risk-benefit assessment of flumazenil in the management of benzodiazepine overdose. Drug Saf 17(3):181\u2013196","journal-title":"Drug Saf"},{"key":"3031_CR6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1365-2796.1989.tb01365.x","volume":"226","author":"J Hojer","year":"1989","unstructured":"Hojer J, Baehrendtz S, Gustafsson L (1989) Benzodiazepine poisoning: experience of 702 admissions to an intensive care unit during a 14-year period. J Intern Med 226:117\u2013122","journal-title":"J Intern Med"},{"issue":"7","key":"3031_CR7","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1111\/j.1399-6576.1991.tb03353.x","volume":"35","author":"J H\u00f6jer","year":"1991","unstructured":"H\u00f6jer J, Baehrendtz S, Magnusson A, Gustafsson LL (1991) A placebo-controlled trial of flumazenil given by continuous infusion in severe benzodiazepine overdosage. Acta Anaesthesiol Scand 35(7):584\u2013590","journal-title":"Acta Anaesthesiol Scand"},{"issue":"7","key":"3031_CR8","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1177\/0960327107078667","volume":"26","author":"H Talaei","year":"2007","unstructured":"Talaei H, Pajouhmand A, Abdollahi M, Panahandeh R, Emami H, Hajinasrollah S, Tghaddosinezhad M (2007) Rhabdomyolysis among acute human poisoning cases. Hum Exp Toxicol 26(7):557\u2013561","journal-title":"Hum Exp Toxicol"},{"issue":"3","key":"3031_CR9","doi-asserted-by":"crossref","first-page":"239","DOI":"10.4103\/1735-1995.156166","volume":"20","author":"SR Mousavi","year":"2015","unstructured":"Mousavi SR, Vahabzadeh M, Mahdizadeh A, Vafaee M, Sadeghi M, Afshari R, Balali-Mood M (2015) Rhabdomyolysis in 114 patients with acute poisonings. J Res Med Sci 20(3):239\u2013243","journal-title":"J Res Med Sci"},{"issue":"6764","key":"3031_CR10","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1136\/bmj.301.6764.1308","volume":"301","author":"J Hojer","year":"1990","unstructured":"Hojer J, Baehrendtz S, Matell G, Gustafsson LL (1990) Diagnostic utility of flumazenil in coma with suspected poisoning: a double blind, randomized controlled study. BMJ. 301(6764):1308\u20131311","journal-title":"BMJ."},{"issue":"3","key":"3031_CR11","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0196-0644(05)82054-2","volume":"19","author":"KK Burkhart","year":"1990","unstructured":"Burkhart KK, Kulig KW (1990) The diagnostic utility of flumazenil (a benzodiazepine antagonist) in coma of unknown etiology. Ann Emerg Med 19(3):319\u2013321","journal-title":"Ann Emerg Med"},{"issue":"4","key":"3031_CR12","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.jemermed.2012.01.059","volume":"43","author":"AA Kreshak","year":"2012","unstructured":"Kreshak AA, Cantrell FL, Clark RF, Tomaszewski CA (2012) A poison center's 10-year experience with flumazenil administration to acutely poisoned adults. J Emerg Med 43(4):677\u2013682","journal-title":"J Emerg Med"},{"issue":"9","key":"3031_CR13","first-page":"179","volume":"137","author":"K Hruby","year":"1987","unstructured":"Hruby K, Prischl F, Smetana R, Pernecker M, Donner A, Scholtz I, Grimm G (1987) Specific therapy of acute benzodiazepine poisoning using flumazenil (Ro15-1788). Wien Med Wochenschr 137(9):179\u2013183 German","journal-title":"Wien Med Wochenschr"},{"key":"3031_CR14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/bcpt.12434","volume":"118","author":"EI Penninga","year":"2016","unstructured":"Penninga EI, Graudal N, Ladekarl MB, J\u00fcrgens G (2016) Adverse events associated with flumazenil treatment for the management of suspected benzodiazepine intoxication \u2013 a systematic review with meta-analyses of randomised trials. Basic Clin Pharmacol Toxicol 118:37\u201344","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"3031_CR15","unstructured":"Flumazenil. Retrieved from: https:\/\/reference.medscape.com\/drug\/romazicon-flumazenil-343731 (accessed June 5th, 2020)."},{"issue":"8","key":"3031_CR16","first-page":"534","volume":"17","author":"H Hassanian-Moghaddam","year":"2014","unstructured":"Hassanian-Moghaddam H, Zamani N, Rahimi M, Shadnia S, Pajoumand A, Sarjami S (2014) Acute adult and adolescent poisoning in Tehran, Iran; the epidemiologic trend between 2006 and 2011. Arch Iran Med 17(8):534\u2013538","journal-title":"Arch Iran Med"},{"key":"3031_CR17","volume-title":"Benzodiazepine toxicity","author":"M Kang","year":"2019","unstructured":"Kang M, Ghassemzadeh S (2019) Benzodiazepine toxicity. Stat Pearls Publishing, Treasure Island (FL)"},{"issue":"5","key":"3031_CR18","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/bcpt.12498","volume":"118","author":"A Pajoumand","year":"2016","unstructured":"Pajoumand A, Hassanian-Moghaddam H, Zamani N (2016) Response to: adverse events associated with flumazenil treatment for the management of suspected benzodiazepine intoxication \u2013 a systematic review with meta-analyses of randomised trials. Basic Clin Pharmacol Toxicol 118(5):323\u2013324","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"3031_CR19","first-page":"1013","volume-title":"Goldfrank\u2019s Toxicologic Emergencies","author":"MA Howland","year":"2015","unstructured":"Howland MA (2015) Antidote in depth, Flumazenil. In: Hoffman RS, Howland MA, Lewin NA, Nelson LS, Goldffrank LR (eds) Goldfrank\u2019s Toxicologic Emergencies, 10th edn. Mc Graw Hill Education, New York, pp 1013\u20131017","edition":"10"},{"key":"3031_CR20","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jcrc.2016.05.003","volume":"35","author":"H Hamdi","year":"2016","unstructured":"Hamdi H, Hassanian-Moghaddam H, Hamdi A, Zahed NS (2016) Acid-base disturbances in acute poisoning and their association with survival. J Crit Care 35:84\u201389","journal-title":"J Crit Care"},{"key":"3031_CR21","first-page":"2,209","volume":"42","author":"DL Seger","year":"2004","unstructured":"Seger DL (2004) Flumazenil\u2014Treatment or Toxin. J Toxicol Clin Toxicol 42:2,209\u20132,216","journal-title":"J Toxicol Clin Toxicol"},{"key":"3031_CR22","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1592\/phco.23.14.1513.31941","volume":"23","author":"JL Maxa","year":"2003","unstructured":"Maxa JL, Ogu CC, Adeeko MA, Swaner TG (2003) Continuous infusion flumazenil in the management of chlordiazepoxide toxicity. Pharmacotherapy 23:1513\u20131516","journal-title":"Pharmacotherapy"},{"issue":"11","key":"3031_CR23","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/j.ajem.2015.07.031","volume":"33","author":"TT Nguyen","year":"2015","unstructured":"Nguyen TT, Troendle M, Cumpston K, Rose SR, Wills BK (2015) Lack of adverse effects from flumazenil administration: an ED observational study. Am J Emerg Med 33(11):1677\u20131679","journal-title":"Am J Emerg Med"},{"issue":"10","key":"3031_CR24","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1111\/j.1553-2712.1997.tb03657.x","volume":"4","author":"CR Chudnofsky","year":"1997","unstructured":"Chudnofsky CR (1997) Safety and efficacy of flumazenil in reversing conscious sedation in the emergency department. Emergency Medicine Conscious Sedation Study Group. Acad Emerg Med 4(10):944\u2013950","journal-title":"Acad Emerg Med"},{"key":"3031_CR25","unstructured":"Wiegand T, Acquisto N (2011) High-dose flumazenil drip for reversal of a massive iatrogenic benzodiazepine overdose; a cause-effect analysis of an Adverse Drug Effect and discussion of the role of the Clinical Pharmacist and Medical Toxicologist. North American Congress of Clinical Toxicology: abstr. 113, 21 2011.\u00a0https:\/\/www.tandfonline.com\/doi\/full\/10.3109\/15563650.2011.598695. Accessed 29 Oct 2020"},{"issue":"1","key":"3031_CR26","doi-asserted-by":"publisher","first-page":"58","DOI":"10.4103\/0974-2700.145422","volume":"8","author":"M Al-Halawani","year":"2015","unstructured":"Al-Halawani M, Sen P, Abdeen Y, Shaaban H, Klukowicz AJ, Miller RA (2015) Continuous intravenous flumazenil infusion in a patient with chlordiazepoxide toxicity and hepatic encephalopathy. J Emerg Trauma Shock 8(1):58\u201360","journal-title":"J Emerg Trauma Shock"},{"key":"3031_CR27","unstructured":"Gussow L, Carlson A (2018) Sedative hypnotics. In: Walls RM, Hockberger RS, Gausche-Hill M (eds) Rosen\u2019s emergency medicine: concepts and clinical practice, 9th edn. Elsevier, Philadelphia, pp 1974-1981"}],"updated-by":[{"DOI":"10.1007\/s00228-021-03117-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T00:00:00Z","timestamp":1614297600000}}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-020-03031-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-020-03031-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-020-03031-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T00:15:49Z","timestamp":1696983349000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-020-03031-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,30]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["3031"],"URL":"https:\/\/doi.org\/10.1007\/s00228-020-03031-7","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00228-021-03117-w","asserted-by":"object"}]},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,30]]},"assertion":[{"value":"18 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00228-021-03117-w","URL":"https:\/\/doi.org\/10.1007\/s00228-021-03117-w","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest that might be relevant to the contents of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"The study was approved by the ethics committee in National Institute for Medical Research Development (IR.NIMAD.REC.1397.305) and registered in Iranian Clinical Trial Registry (IRCT20120629010133N3).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Patients\u2019 relatives accompanying them to ED were explained about the process of the study and written informed consents were taken from them all before patient enrollment. Patients that were awake after the initial flumazenil administration give consent for themselves as well. All data are de-identified in this database to remove patients\u2019 information. Ethic committee waived consent for publication with this conditional issue.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate and publication"}}]}}